MiNK Therapeutics, Inc.
INKT
$11.90
$0.453.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.07% | -5.39% | 9.89% | 31.86% | -53.17% |
| Total Depreciation and Amortization | 0.00% | -6.48% | -11.67% | -10.45% | -3.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -33.03% | 2,975.12% | -97.56% | -42.05% | 85.27% |
| Change in Net Operating Assets | 71.02% | -26.86% | -55.76% | -9.11% | 97.51% |
| Cash from Operations | -20.21% | 16.45% | -120.30% | 40.01% | -17.03% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -56.64% | 133.66% | -90.04% | 2,709,040.00% | -16.67% |
| Repurchase of Common Stock | 100.00% | -45.21% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 165.03% | -278.78% | -91.32% | 2,709,040.00% | -16.67% |
| Foreign Exchange rate Adjustments | -66.67% | 94.59% | -344.00% | -131.85% | 972.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 81.26% | -316.41% | -107.31% | 911.29% | -15.71% |